ARTICLE | Clinical News
Arformoterol tartrate: Phase III data
May 29, 2006 7:00 AM UTC
In a double-blind, placebo-controlled, salmeterol-controlled Phase III trial in 717 patients, arformoterol led to significant improvement in airway function, as measured by FEV1, over 12 weeks vs. pla...